Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Sep 09, 2021 2:18pm
151 Views
Post# 33834462

Fellow Investors !!!

Fellow Investors !!!14 Million is we kept it and run thru phase 3 ourselves ....it could be sold as part of a combined deal ...maybe get enough to pay off Talent possibly a bit more to put in our pockets .. better then nothing and anything is possible .. what if Talent rejected the return and now we have the debt of 4 mil to pay ..while it rots on the shelf or will we have to pay more to Talent ...how much was offered b4 that Rob felt was not enough.. there were a few interested parties according to Bob in Aug 30 MD&A ....as for people getting kicked off the other sites .. I didn't really care and said it was your sites to run the way you want ...I know I am still part but I was spending too much time on and kept to my original board because I follow my other stks ... but like you say facts are for cockroaches ...and the only facts I am concerned with is what comes directly from the company.. I was trying to show my support but I guess it wasn't to certain likings .. I guess maybe I would have got myself kicked off if I stayed and posted my thoughts ... cause as you can see I argue from my seat with my thoughts .. but it doesn't mean I am against the company leadership ..products nor other investors ....gltal
<< Previous
Bullboard Posts
Next >>